McKesson Corp (MCK)

147.18
2.50 1.73
NYSE : Services
Prev Close 144.68
Open 145.51
Day Low/High 145.06 / 147.76
52 Wk Low/High 114.53 / 199.43
Volume 1.27M
Avg Volume 2.69M
Exchange NYSE
Shares Outstanding 226.09M
Market Cap 32.71B
EPS 9.80
P/E Ratio 16.24
Div & Yield 1.12 (0.80%)

Latest News

McKesson Corporation Fiscal 2017 Third Quarter Conference Call Scheduled For January 25, 2017

McKesson Corporation Fiscal 2017 Third Quarter Conference Call Scheduled For January 25, 2017

McKesson Corporation (NYSE:MCK) will release financial results for its third fiscal quarter, ended December 31, 2016, on Wednesday, January 25, 2017, following market close at approximately 4:00 PM Eastern Time (1:00 PM...

Mizuho Analysts Share Their Top Stock Picks for 2017

Mizuho Analysts Share Their Top Stock Picks for 2017

Apple, Energen and McKesson are among the top stock picks of Mizuho's analysts for 2017.

McKesson Completes Acquisition Of Rexall Health And Appoints Domenic Pilla As CEO Of McKesson Canada

McKesson Completes Acquisition Of Rexall Health And Appoints Domenic Pilla As CEO Of McKesson Canada

McKesson Corporation (NYSE:MCK), a leading international healthcare services and information technology company, announced today that it has completed the previously announced acquisition of Rexall Health for $2.

McKesson And Change Healthcare Announce Termination Of Hart-Scott-Rodino Act Waiting Period For The Creation Of A New Healthcare Information Technology Company

McKesson And Change Healthcare Announce Termination Of Hart-Scott-Rodino Act Waiting Period For The Creation Of A New Healthcare Information Technology Company

McKesson Corporation (NYSE:MCK), a leading global healthcare services and information technology company, and Change Healthcare Holdings, Inc.

McKesson Corporation To Present At The 35th Annual J.P. Morgan Healthcare Conference

McKesson Corporation To Present At The 35th Annual J.P. Morgan Healthcare Conference

McKesson Corporation (NYSE:MCK) today announced that John Hammergren, chairman and chief executive officer, will present at the 35 th Annual J.

Apple, Alphabet, Starbucks: Doug Kass' Views

Apple, Alphabet, Starbucks: Doug Kass' Views

Doug Kass shares his thoughts on divergences in the market's armor and observes that real tech regulation is complicated.

Technical Analysis Shows Trio of Healthcare Stocks May Not Be Buys Yet

Technical Analysis Shows Trio of Healthcare Stocks May Not Be Buys Yet

The charts for Cerner, Eli Lilly and McKesson do not flash buy signals.

McKesson Receives Regulatory Approval For Rexall Health Acquisition

McKesson Receives Regulatory Approval For Rexall Health Acquisition

McKesson Corporation (NYSE: MCK) today announced that it has signed a consent agreement with the Competition Bureau of Canada allowing it to proceed with the acquisition of Rexall Health (inclusive of Rexall/Pharma Plus,...

3 Beat-Up Health Care Stocks to Buy Now

3 Beat-Up Health Care Stocks to Buy Now

Cerner, Eli Lilly and McKesson are three health care companies that are trading at a bargain.

3 Bargain-Priced Health-Care Stocks

3 Bargain-Priced Health-Care Stocks

Current valuations are at record lows, despite the companies having good prospects.

Analysts' Actions -- Analog Devices, Abercrombie, CBS, McKesson and More

Analysts' Actions -- Analog Devices, Abercrombie, CBS, McKesson and More

Here are Wednesday's top research calls, including downgrades for Abercrombie & Fitch, CBS and McKesson, and an upgrade for Analog Devices.

Uncertainties Making it Difficult for Investors in the Healthcare Sector, says Mizuho Analyst

Uncertainties Making it Difficult for Investors in the Healthcare Sector, says Mizuho Analyst

Since the election, big questions remain about investing in hospital and healthcare stocks, and the group will remain volatile according to Mizuho.

Andrew Left: Dump Mallinckrodt

Andrew Left: Dump Mallinckrodt

Famed short-seller says drugmaker at risk of a government crackdown.

Allergan, Macy's, Apple: Doug Kass' Views

Allergan, Macy's, Apple: Doug Kass' Views

Doug Kass shares his thoughts on closed-end municipal bond funds.

Cisco, Allergan, Facebook: Doug Kass' Views

Cisco, Allergan, Facebook: Doug Kass' Views

Doug Kass shares his thoughts on the bond market's bounciness and stocks suffering election uncertainty.

NKE, AGN, NFLX: Jim Cramer's Views

NKE, AGN, NFLX: Jim Cramer's Views

Cramer shares his views on price war victims. Nike, Allergan and Netflix are among the stocks discussed.

SBUX, AAPL, FB: Jim Cramer's Views

SBUX, AAPL, FB: Jim Cramer's Views

Cramer shares his views on the rise of the stay-at-home consumer. Starbucks, Apple and Facebook are among the stocks discussed.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ANH, CCRN, CPE, DVCR, ESRT, LBRDA, LBRDK, MIXT, MTGE, ORN, PWR, ROG, TTWO, TWO, USCR Downgrades: AGU, ARC, CHTR, DPLO, EGN, ELY, F, FOMX, GNE, GTN.A, GTS, MCK, SIRI, THS, XOXO, ZEUS Initiations: KHC Read on to get TheStreet Quant Ratings' detailed report:

Cramer: Don't Just Stand There Like Bambi; Sell Some

Cramer: Don't Just Stand There Like Bambi; Sell Some

Stocks in the health care sector seem to have no underpinnings whatsoever.

Cramer: Health Care Sector Is Hurting

Cramer: Health Care Sector Is Hurting

You can't ignore the evidence.

ZBH's Big Unjustified Price Correction

ZBH's Big Unjustified Price Correction

Shares are trading at less than 12.5x 2017's EPS estimates and should rise soon.

Valeant Skyrockets on Rumored $10B Salix Sale

Valeant Skyrockets on Rumored $10B Salix Sale

Investors rush to buy the drugmaker's stock following chatter of a much-needed megadeal.

Cramer: How Bad Was Today? Let Us Count the Ways

Cramer: How Bad Was Today? Let Us Count the Ways

Today there was a virtual vacuum of good news in the stock market.

Jim Cramer Says Pricing Pressure is the Reason Not to Buy Valeant

Jim Cramer Says Pricing Pressure is the Reason Not to Buy Valeant

Jim Cramer says there are other reasons not to buy Valeant, other than the criminal investigation.

Morning Movers: PFE, K, VRX, AEP

Morning Movers: PFE, K, VRX, AEP

Pfizer shares were slipping after the drugmaker posted a premarket earnings whiff.

Federal Probe Is No Halloween Treat for Valeant

Federal Probe Is No Halloween Treat for Valeant

Valeant shares drop as regulators investigate possible accounting fraud.

Valeant's Frightful Halloween

Valeant's Frightful Halloween

Troubled drug firm sheds 12% on fresh fraud news.

Cramer: Nike Is a Victim of Price Wars; There Will Be Others

Cramer: Nike Is a Victim of Price Wars; There Will Be Others

Look out below when it comes to margins, as the price wars extend to sneakers, drugs and others.